Publicaciones en las que colabora con MARIO FERNANDEZ FRAGA (13)

2024

  1. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma

    eBioMedicine, Vol. 102

2023

  1. The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Classification of follicular-patterned thyroid lesions using a minimal set of epigenetic biomarkers

    European journal of endocrinology, Vol. 187, Núm. 3, pp. 335-347

2020

  1. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis

    International Journal of Cancer, Vol. 146, Núm. 2, pp. 373-387

2019

  1. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

    Nucleic Acids Research, Vol. 47, Núm. 10, pp. 5016-5037

  2. Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations

    The Journal of clinical endocrinology and metabolism, Vol. 104, Núm. 11, pp. 5673-5692

2018

  1. Epigenetic dysregulation of TET2 in human glioblastoma

    Oncotarget, Vol. 9, Núm. 40, pp. 25922-25934

  2. SDHC promoter methylation, a novel pathogenic mechanism in parasympathetic paragangliomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 1, pp. 295-305

2016

  1. HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: Evidence for regulation by epigenetic mechanisms

    Scientific Reports, Vol. 6

2014

  1. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia

    Nature Communications, Vol. 5

2013

  1. DNA methylation signatures identify biologically distinct thyroid cancer subtypes

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 7, pp. 2811-2821

  2. Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion

    Nature Communications, Vol. 4

2012

  1. Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: Pathobiological mechanisms and clinical implications

    Journal of Molecular Medicine, Vol. 90, Núm. 10, pp. 1173-1184